5 unchanged sentences
Not Applicable.
+Added: Table of C o ntent s
Executive Officers of the Registrant (ages as of February 1, 2024)
2 unchanged sentences
Name Age Offices and Business Experience
−Removed: Davis 56 Chairman, President and Chief Executive Officer (since December 2022);
+Added: Davis 57 Chairman, Chief Executive Officer and President (since December 2022);
Chief Executive Officer and President (July 2021-December 2022);
3 unchanged sentences
Cristal Downing 55 Executive Vice President and Chief Communications & Public Affairs Officer (since August 2021);
−Removed: Vice President Medical Devices, Global Communications and Public Affairs Johnson & Johnson (December 2020-August 2021);
+Added: Prior to that, Vice President Medical Devices, Global Communications and Public Affairs Johnson & Johnson (December 2020-August 2021);
Vice President Financial Communication, Johnson & Johnson (January 2018-December 2020)
−Removed: Prior to that, Senior Director Communications at Johnson & Johnson
Chirfi Guindo 58 Senior Vice President, Chief Marketing Officer, Human Health (since July 2022);
1 unchanged sentence
(July 2018-July 2022)
−Removed: Executive Vice President, Head of Global Marketing, Market Access and Customer Innovation, Biogen Inc.
−Removed: (November 2017-June 2018)
−Removed: Karachun 59 Senior Vice President Finance - Global Controller (since March 2014)
Klobuchar 48 Executive Vice President, Chief Strategy Officer (since July 2021);
Senior Vice President, CFO of Merck R&D and Head of Global Portfolio and Alliance Management (January 2019-June 2021)
−Removed: Senior Vice President of Corporate Strategy and Planning and President of Emerging Businesses (December 2017-January 2019)
−Removed: Lisa LeCointe-Cephas 41 Senior Vice President, Chief Ethics and Compliance Officer (since April 2021);
−Removed: Executive Director, Head of Global Investigations (February 2018-April 2021);
−Removed: Prior to that, Senior Counsel, Litigation and Government Investigations, Bristol-Myers Squibb Company
Dean Li 61 Executive Vice President, President, Merck Research Laboratories (since January 2021);
Senior Vice President, Discovery Sciences and Translational Medicine, Merck Research Laboratories (November 2017-January 2021)
−Removed: Vice President, Translational Medicine (March 2017-November 2017)
Caroline Litchfield 55 Executive Vice President and Chief Financial Officer (since April 2021);
1 unchanged sentence
63 Executive Vice President, Chief Human Resources Officer (since October 2018)
−Removed: Prior to that, Executive Vice President, Human Resources, Monsanto Company
56 Senior Vice President and President Merck U.S.
4 unchanged sentences
Joseph Romanelli 50 Senior Vice President and President MSD International Human Health (since July 2022);
−Removed: Chief Executive Officer JiXing Pharmaceuticals (July 2021-July 2022);
+Added: Prior to that, Chief Executive Officer JiXing Pharmaceuticals (July 2021-July 2022);
President MSD China (December 2016-July 2021)
+Added: 57 Senior Vice President Finance – Global Controller (since December 2023);
+Added: Vice President, Assistant Controller (September 2023-December 2023);
+Added: Vice President, Internal Audit (March 2015-September 2023)
Williams 55 Executive Vice President, Chief Information and Digital Officer (since August 2020);
1 unchanged sentence
Vice President and Chief Information Officer, Merck Animal Health (May 2017-December 2019)
−Removed: Jennifer Zachary 45 Executive Vice President, General Counsel and Corporate Secretary (since January 2020);
−Removed: Executive Vice President and General Counsel (April 2018-January 2020);
−Removed: Prior to that, Partner, Covington & Burling LLP
+Added: Jennifer Zachary 46 Executive Vice President and General Counsel (since April 2018)
+Added: On February 1, 2024, the Company announced that Steven C.
+Added: Mizell, chief human resources officer, will retire from the Company, effective July 1 , 2024.
+Added: On February 5, 2024, the Company announced that Ms.
+Added: Larson will join the Company and assume the role as chief human resources officer, effective at the beginning of April 2024, at which time Ms.
+Added: Larson will become, and Mr.
+Added: Mizell will cease to be, an Executive Officer of the Company.
+Added: Mizell will remain in a strategic advisory role at the Company until his retirement.
+Added: Offices and Business Experience
+Added: 48 Chief People Officer, GE HealthCare (since February 2022);
+Added: Executive Vice President and Chief Human Resources Officer, Becton Dickinson (June 2018-February 2022)
+Added: Table of C o ntent s
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.